MY
Megan Younger
View Megan's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Company Details
ALPHADAS®, is the market leading e-Source, pro-active EDC system designed predominantly for Early Phase clinical trials which addresses the needs of investigators and sponsors alike. A market proven, world class product which is currently used in four continents by small to large early phase clinical research organizations and top 10 pharmaceuticals. ALPHADAS is a mobile, schedule-driven, event based automation system that provides real-time pro-active EDC at the bedside, station or remote location. Its ability to integrate with medical devices, central ECG systems and central laboratories means minimum human data entry is required, simultaneously reducing human error & increasing efficiency, yielding immediate significant returns on investment. Site specific tools provide workflow driven automation through time driven & status based events as well as bar-coded sample tracking, further improving quality and traceability. Its depth of proven functionality over other systems to date has been untouched. Logos Technologies’ dedicated team behind ALPHADAS are ‘Experts in Early Phase EDC’ & provide an unrivalled level of service, experience and expertise to its clients. ALPHADAS is a modular, flexible &scalable solution that can encompass a clients bespoke requirements and, coupled with Logos Technologies dynamic, flexible and partnership orientated approach to a clients business requirements makes for a compelling proposition that delivers impressive returns for our clients.
Year Founded
1995
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing
HQ Location
Peterborough Road London, SW6 3BU, GB
Keywords
Experts in Early Phase EDCePROAutomation of Clinical Trialsand Workflow management
Discover More About Cleveland Clinic

Find verified contacts of Megan Younger in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.